Reversible Splenial Lesion Syndrome (RESLES): What's in a Name?

Journal of Neuroimaging

Volumn 21, Issue 2, 2011, Pages

  Garcia Monco, Juan Carlos ^a,b   Cortina, Ines Escalza ^a,b   Ferreira, Eva ^a,b   Martínez, Amaia ^a,b   Ruiz, Lara ^a,b   Cabrera, Alberto ^a,b   Beldarrain, Marian Gomez ^a,b  

^a HOSPITAL DE GALDAKAO   (Spain)

^b Magnetic Resonance Unit   (Spain)

Author keywords

Antiepileptic drugs; Corpus callosum; Encephalitis; Encephalopathy; MRI; Reversible lesions; Seizures; Splenium

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; CARBAMAZEPINE; CARBOPLATIN; CISPLATIN; CITALOPRAM; FLUOROURACIL; LAMOTRIGINE; METHYL BROMIDE; OLANZAPINE; PHENYTOIN;

ADULT; ANOREXIA NERVOSA; BRAIN DISEASE; BRAIN EDEMA; CALLOSAL DISCONNECTION SYNDROME; CASE REPORT; CLINICAL FEATURE; CORPUS CALLOSUM; CYANOCOBALAMIN DEFICIENCY; DRUG WITHDRAWAL; ENCEPHALITIS; FEMALE; HEREDITARY MOTOR SENSORY NEUROPATHY; HIGH ALTITUDE CEREBRAL EDEMA; HUMAN; HYPERNATREMIA; HYPOGLYCEMIA; INFECTION; MALE; MALNUTRITION; MARCHIAFAVA BIGNAMI DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; REVERSIBLE SPLENIAL LESION SYNDROME; REVIEW; SEIZURE; SYSTEMIC LUPUS ERYTHEMATOSUS;

AGED; ANTICONVULSANTS; CORPUS CALLOSUM; ENCEPHALITIS; EPILEPSY; FEMALE; HUMANS; HYPERNATREMIA; HYPOGLYCEMIA; MAGNETIC RESONANCE IMAGING; MALE; NERVE FIBERS, MYELINATED; RISK FACTORS; YOUNG ADULT;

EID: 79953037275     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2008.00279.x     Document Type: Review

References (51)

1. McLeod NA, Williams JP, Machen B, Lum GB. Normal and abnormal morphology of the corpus callosum. Neurology 1987;37:1240-1242.
2. Oaklander AL, Buchbinder BR. Pregabalin-withdrawal encephalopathy and splenial edema: a link to high-altitude illness Ann Neurol 2005;58:309-312.
3. Prilipko O, Delavelle J, Lazeyras F, Seeck M. Reversible cytotoxic edema in the splenium of the corpus callosum related to antiepileptic treatment: report of two cases and literature review. Epilepsia 2005;46:1633-1636.
4. da Rocha AJ, Reis F, Gama HP, da Silva CJ, Braga FT, Junior AC, Cendes F. Focal transient lesion in the splenium of the corpus callosum in three non-epileptic patients. Neuroradiology 2006;48:731-735.
5. Kizilkilic O, Karaca S. Influenza-associated encephalitis-encephalopathy with a reversible lesion in the splenium of the corpus callosum: case report and literature review. AJNR Am J Neuroradiol 2004;25:1863-1864.
6. Bulakbasi N, Kocaoglu M, Tayfun C, Ucoz T. Transient splenial lesion of the corpus callosum in clinically mild influenza-associated encephalitis/encephalopathy. AJNR Am J Neuroradiol 2006;27:1983-1986.
7. Takanashi J, Barkovich AJ, Shiihara T, Tada H, Kawatani M, Tsukahara H, Kikuchi M, Maeda M. Widening spectrum of a reversible splenial lesion with transiently reduced diffusion. AJNR Am J Neuroradiol 2006;27:836-838.
8. Hagemann G, Mentzel HJ, Weisser H, Kunze A, Terborg C. Multiple reversible MR signal changes caused by Epstein-Barr virus encephalitis. AJNR Am J Neuroradiol 2006;27:1447-1449.
9. Kobuchi N, Tsukahara H, Kawamura Y, Ishimori Y, Ohshima Y, Hiraoka M, Hiraizumi Y, Ueno M, Mayumi M. Reversible diffusion-weighted MR findings of Salmonella enteritidis-associated encephalopathy. Eur Neurol 2003;49:182-184.
10. Kato Z, Kozawa R, Hashimoto K, Kondo N. Transient lesion in the splenium of the corpus callosum in acute cerebellitis. J Child Neurol 2003;18:291-292.
11. Bottcher J, Kunze A, Kurrat C, Schmidt P, Hagemann G, Witte OW, Kaiser WA. Localized reversible reduction of apparent diffusion coefficient in transient hypoglycemia-induced hemiparesis. Stroke 2005;36:e20-e22.
12. Kang K, Song YM, Jo KD, Roh JK. Diffuse lesion in the splenium of the corpus callosum in patients with methyl bromide poisoning. J Neurol Neurosurg Psychiatry 2006;77:703-704.
13. Tha KK, Terae S, Sugiura M, Nishioka T, Oka M, Kudoh K, Kaneko K, Miyasaka K. Diffusion-weighted magnetic resonance imaging in early stage of 5-fluorouracil-induced leukoencephalopathy. Acta Neurol Scand 2002;106:379-386.
14. Maeda M, Tsukahara H, Terada H, Nakaji S, Nakamura H, Oba H, Igarashi O, Arasaki K, Machida T, Takeda K, Takanashi JI. Reversible splenial lesion with restricted diffusion in a wide spectrum of diseases and conditions. J Neuroradiol 2006;33:229-236.
15. Pekala JS, Mamourian AC, Wishart HA, Hickey WF, Raque JD. Focal lesion in the splenium of the corpus callosum on FLAIR MR images: a common finding with aging and after brain radiation therapy. AJNR Am J Neuroradiol 2003;24:855-861.
16. Tobita M, Mochizuki H, Takahashi S, Onodera H, Itoyama Y, Iwasaki Y. A case of Marchiafava-Bignami disease with complete recovery: sequential imaging documenting improvement of callosal lesions. Tohoku J Exp Med 1997;182:175-179.
17. Appenzeller S, Faria A, Marini R, Costallat LT, Cendes F. Focal transient lesions of the corpus callosum in systemic lupus erythematosus. Clin Rheumatol 2006;25:568-571.
18. Saito K, Kimura K, Minematsu K, Shiraishi A, Nakajima M. Transient global amnesia associated with an acute infarction in the retrosplenium of the corpus callosum. J Neurol Sci 2003;210:95-97.
19. Fogel B, Cardenas D, Ovbiagele B. Magnetic resonance imaging abnormalities in the corpus callosum of a patient with neuropsychiatric lupus. Neurologist 2006;12:271-273.
20. Nelles M, Bien CG, Kurthen M, von Falkenhausen M, Urbach H. Transient splenium lesions in presurgical epilepsy patients: incidence and pathogenesis. Neuroradiology 2006;48:443-448.
21. Doherty MJ, Jayadev S, Watson NF, Konchada RS, Hallam DK. Clinical implications of splenium magnetic resonance imaging signal changes. Arch Neurol 2005;62:433-437.
22. Polster T, Hoppe M, Ebner A. Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis. J Neurol Neurosurg Psychiatry 2001;70:459-463.
23. Bourekas EC, Varakis K, Bruns D, Christoforidis GA, Baujan M, Slone HW, Kehagias D. Lesions of the corpus callosum: MR imaging and differential considerations in adults and children. AJR Am J Roentgenol 2002;179:251-257.
24. Oster J, Doherty C, Grant PE, Simon M, Cole AJ. Diffusion-weighted imaging abnormalities in the splenium after seizures. Epilepsia 2003;44:852-854.
25. Hackett PH, Yarnell PR, Hill R, Reynard K, Heit J, McCormick J. High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. JAMA 1998;280:1920-1925.
26. Finelli PF. Diffusion-weighted MR in hypoglycemic coma. Neurology 2001;57:933.
27. Aboitiz F, Scheibel AB, Fisher RS, Zaidel E. Fiber composition of the human corpus callosum. Brain Res 1992;598:143-153.
28. Winslow H, Mickey B, Frohman EM. Sympathomimetic-induced kaleidoscopic visual illusion associated with a reversible splenium lesion. Arch Neurol 2006;63:135-137.
29. Chung Park K, Jeong Y, Hwa Lee B, Kim EJ, Moon Kim G, Heilman KM, Na DL. Left hemispatial visual neglect associated with a combined right occipital and splenial lesion: another disconnection syndrome. Neurocase 2005;11:310-318.
30. Kim SS, Chang KH, Kim ST, Suh DC, Cheon JE, Jeong SW, Han MH, Lee SK. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity AJNR Am J Neuroradiol 1999;20:125-129.
31. Cohen-Gadol AA, Britton JW, Jack CR, Jr., Friedman JA, Marsh WR. Transient postictal magnetic resonance imaging abnormality of the corpus callosum in a patient with epilepsy. Case report and review of the literature. J Neurosurg 2002;97:714-717.
32. Mirsattari SM, Lee DH, Jones MW, Blume WT. Transient lesion in the splenium of the corpus callosum in an epileptic patient. Neurology 2003;60:1838-1841.
33. Narita H, Odawara T, Kawanishi C, Kishida I, Iseki E, Kosaka K. Transient lesion in the splenium of the corpus callosum, possibly due to carbamazepine. Psychiatry Clin Neurosci 2003;57:550-551.
34. Maeda M, Shiroyama T, Tsukahara H, Shimono T, Aoki S, Takeda K. Transient splenial lesion of the corpus callosum associated with antiepileptic drugs: evaluation by diffusion-weighted MR imaging. Eur Radiol 2003;13:1902-1906.
35. Honda K, Nishimiya J, Sato H, Munakata M, Kamada M, Iwamura A, Nemoto H, Sakamoto T, Yuasa T. Transient splenial lesion of the corpus callosum after acute withdrawal of antiepileptic drug: a case report. Magn Reson Med Sci 2006;5:211-215.
36. Takanashi J, Barkovich AJ, Yamaguchi K, Kohno Y. Influenza-associated encephalitis/encephalopathy with a reversible lesion in the splenium of the corpus callosum: a case report and literature review. AJNR Am J Neuroradiol 2004;25:798-802.
37. Takanashi J, Hirasawa K, Tada H. Reversible restricted diffusion of entire corpus callosum. J Neurol Sci 2006;247:101-104.
38. Kobata R, Tsukahara H, Nakai A, Tanizawa A, Ishimori Y, Kawamura Y, Ushijima H, Mayumi M. Transient MR signal changes in the splenium of the corpus callosum in rotavirus encephalopathy: value of diffusion-weighted imaging. J Comput Assist Tomogr 2002;26:825-828.
39. Ogura H, Takaoka M, Kishi M, Kimoto M, Shimazu T, Yoshioka T, Sugimoto H. Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy. AJNR Am J Neuroradiol 1998;19:1144-1145.
40. Morgan JC, Cavaliere R, Juel VC. Reversible corpus callosum lesion in legionnaires' disease. J Neurol Neurosurg Psychiatry 2004;75:651-654.
41. Tada H, Takanashi J, Barkovich AJ, Oba H, Maeda M, Tsukahara H, Suzuki M, Yamamoto T, Shimono T, Ichiyama T, Taoka T, Sohma O, Yoshikawa H, Kohno Y. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology 2004;63:1854-1858.
42. Yaguchi M, Yaguchi H, Itoh T, Okamoto K. Encephalopathy with isolated reversible splenial lesion of the corpus callosum. Intern Med (Tokyo, Japan) 2005;44:1291-1294.
43. Shimizu H, Kataoka H, Yagura H, Hirano M, Taoka T, Ueno S. Extensive neuroimaging of a transient lesion in the splenium of the corpus callosum. Eur J Neurol 2007;14:e37-e39.
44. Kim SY, Goo HW, Lim KH, Kim ST, Kim KS. Neonatal hypoglycaemic encephalopathy: diffusion-weighted imaging and proton MR spectroscopy. Pediatr Radiol 2006;36:144-148.
45. Kim JH, Choi JY, Koh SB, Lee Y. Reversible splenial abnormality in hypoglycemic encephalopathy. Neuroradiology 2007;49:217-222.
46. Horak EL, Jenkins AJ. Postmortem tissue distribution of olanzapine and citalopram in a drug intoxication. J Forensic Sci 2005;50:679-681.
47. Wong SH, Turner N, Birchall D, Walls TJ, English P, Schmid ML. Reversible abnormalities of DWI in high-altitude cerebral edema. Neurology 2004;62:335-336.
48. Nishimura K, Takei N, Suzuki K, Kawai M, Sekine Y, Isoda H, Mori N. A transient lesion in splenium of the corpus callosum in a patient with childhood-onset anorexia nervosa. Int J Eat Disord 2006;39:527-529.
49. Kosugi T, Isoda H, Imai M, Sakahara H. Reversible focal splenial lesion of the corpus callosum on MR images in a patient with malnutrition. Magn Reson Med Sci 2004;3:211-214.
50. Kori S. Hyperintense splenium in vitamin B12 deficiency. Neurol India 2005;53:377-378.
51. Okada K, Fujiwara H, Tsuji S. X-linked Charcot-Marie-Tooth disease with transient splenium lesion on MRI. Intern Med (Tokyo, Japan) 2006;45:33-34.